M Ventures

M Ventures invests in innovative technologies and products with the potential to significantly impact Merck‘s core business areas.

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Detailed M Ventures Information

Geographic Data

M Ventures headquarters map

Address: Gustav Mahlerplein 102 Toyo lto Building

City: Amsterdam

State: noord-holland

Zip: 1082 MA

Country: NL

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$677M

Metrics

8,401,931Website Global Rank

315Website Monthly Traffic

Twitter Followers

Description

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
3/2020 Xilio Therapeutics Series B 100.5M
9/2016 IOmx Therapeutics Series A 44.6M
10/2021 IOmx Therapeutics Series B 0
7/2016 Progyny Series B 14.7M
2/2021 Medisafe Series C 0
6/2023 Astraveus Seed Round 0
5/2018 Akili Interactive Labs Series C 0
5/2021 Akili Interactive Labs Series D 0
2/2022 Plexium Series B 0
10/2022 Metalenz Series B 0
1/2023 Rewind Therapeutics Series B -
5/2019 Altoida Series A 6.3M
11/2015 ObsEva Series B 58.9M
11/2019 ResoTher Pharma Seed Round 2.4M
4/2021 Anavo Therapeutics Seed Round 0
2/2018 FanAI Seed Round 2.5M
12/2022 Sonde Health Series B 19.3M
5/2022 PictorLabs Series A 0
9/2020 Mosa Meat Series B 0
8/2017 Alcan Systems Series A 8.8M
5/2021 MemryX Series A -
9/2015 Asceneuron Series A 30.8M
2/2023 UNISERS Seed Round 14M
4/2014 Padlock Therapeutics Series A 14.7M
3/2013 Calypso Biotech Seed Round 3.3M
6/2017 iOnctura Seed Round -
4/2009 Ambrx Series D 10M
2/2019 Calypso Biotech Series A 22.7M
9/2021 Calypso Biotech Series A 0
6/2009 Anaphore Series A 13M
1/2022 Future Fertility Series A -
10/2017 Peratech Equity 12.4M
3/2014 Bird Rock Bio Series B 0
4/2019 Sonde Health Series A 0
1/2020 iOnctura Series A 16.6M
2/2014 Synaffix BV Series A -
2/2021 Metalenz Series A 10M
1/2012 Galecto Seed Round -
4/2013 Canbex Therapeutics Venture Round 3.2M
6/2023 Celestial AI Series B 100M
9/2021 Legendairy Foods Series A 0
11/2017 Wiliot Series A 5M
3/2017 Medisafe Series B 0
8/2018 ApoGen Biotechnologies Series A 4M
1/2017 ARTSaVIT Series A 6.3M
9/2020 NanoSyrinx Pre Seed Round -
11/2021 Biolinq Series B 0
7/2021 Wiliot Series C 0
11/2020 F-Star Therapeutics Post-IPO Equity 0
7/2020 iOnctura Series A 5.8M
5/2018 Gamelynx Equity 1.2M
8/2021 Immunitas Therapeutics Series B 0
1/2017 Macrophage Pharma Series A 0
2/2017 Prexton Therapeutics Series B 31.1M
10/2018 Galecto Series C 90.2M
11/2021 NeoLogic (VLSI) Seed Round 2.8M
7/2021 Artios Pharma Series C 0
8/2018 Vantage Point Pre Seed Round 1.4M
3/2022 Concerto Biosciences Equity 24.5M
6/2017 Indi Molecular Series A 0
5/2020 SynSense Series A -
7/2019 Forendo Pharma Venture Round 0
9/2016 Artios Pharma Series A 0
5/2019 Storm Therapeutics Series A 17.8M
7/2021 NanoSyrinx Seed Round 8.5M
2/2018 FanAI Venture Round 0
11/2018 curbFlow Seed Round -
7/2020 DNA Script Series B 50M
9/2017 DNA Script Series A 13.2M
8/2018 Vantage Point Pre Seed Round 0
2/2015 Prexton Therapeutics Series A 10M
11/2020 Ferroelectric Memory Company Series B 0
10/2013 Galecto Series B 6.3M
12/2022 Storm Therapeutics Series B 30M
1/2012 Translate Bio Series A 20.7M
10/2021 DNA Script Series C 0
7/2016 Akili Interactive Labs Series B 42.4M
10/2017 aveni Series B 10.5M
2/2022 Celestial AI Series A 56M
7/2018 Mosa Meat Series A 0
3/2022 Concerto Biosciences Series A 24.5M
12/2019 Neurable Series A 6M
11/2018 Ribometrix Series A 30M
7/2015 Translate Bio Series B 0
4/2011 F-Star Therapeutics Venture Round 0
6/2018 Mighty Bear Games Seed Round 2.5M
1/2021 Theolytics Series A 6.8M
10/2014 Forendo Pharma Series A 0
6/2018 Inthera Bioscience Series A 0
10/2022 Nucleome Therapeutics Series A 42.3M
9/2020 Tipe Seed Round 2.1M
3/2023 PxE Seed Round 0
2/2022 Micropsi Industries Series B 0
3/2019 Biolinq Series A 4.8M
11/2017 Biolinq Series A 0
6/2020 Micropsi Industries Series A -
10/2013 F-Star Therapeutics Series A 0
5/2009 Bird Rock Bio Series A 13M
1/2010 F-Star Therapeutics Series A 11.5M
5/2021 Soteria Biotherapeutics Series A 42M
4/2016 Metabomed Series A 18M
1/2018 Rewind Therapeutics Series A 18.3M
10/2014 Raze Therapeutics Series A 24M
1/2023 Rewind Therapeutics Series A -
2/2020 Scipio Bioscience Series A 6.5M
4/2020 FoRx Therapeutics Seed Round 10.8M
6/2016 Storm Therapeutics Series A 16M
7/2019 SIMULATE Seed Round 7M
9/2020 SeeQC Series A 22.4M
3/2022 Altoida Series A 0
9/2018 Forendo Pharma Venture Round 0
5/2017 Inthera Bioscience Series A 0
3/2022 Altoida Series A 0
2/2022 Plexium Series B 0
2/2022 Micropsi Industries Series B 0
2/2022 Celestial AI Series A 0
1/2022 Future Fertility Series A -
11/2021 NeoLogic (VLSI) Seed Round 0
11/2021 Biolinq Series B 0
10/2021 DNA Script Series C 0
10/2021 IOmx Therapeutics Series B 0
9/2021 Legendairy Foods Series A 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research